※ 引述《askacis (ASKA)》之銘言：
: 拿到EUA的那幾家藥廠基本上測新型變種也是先直接測中和抗體，
: 因為根本沒時間讓你重作大型臨床，至於之後會不會補大型臨床實驗，
: 就要看他們之後有沒有發paper了
A test negative case-control design was used to
estimate odds ratios for testing positive to SARS-CoV-2
in all vaccinated compared with unvaccinated people
with compatible symptoms who were tested using
polymerase chain reaction (PCR).
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
https://doi.org/10.1101/2021.05.22.21257658
paper 已經發了
妳是在作什麼中和抗體夢?
他們數據都有了 直接統計技術即可